Tenax Therapeutics Inc. (NASDAQ: TENX) Attends 31st Annual ROTH Conference
Tenax Therapeutics (NASDAQ: TENX) is a specialty pharmaceutical company focused on identifying and developing drugs that address diseases with high unmet medical need. The company has a world-class scientific team including recognized global experts in pulmonary hypertension. The company owns the North American rights to develop and commercialize levosimendan and has initiated a phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with heart failure and preserved ejection fraction. For more information, visit the company's website at www.tenaxthera.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1)…







